Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy
Clinical trial NCT07526857 · COMPLETED
Trial details
- NCT number
- NCT07526857
- Sponsor
- Federico II University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.